Please select the option that best describes you:
Do you routinely stop ESA when starting myelofibrosis patients on JAK inhibitor therapy?
Answer from: at Academic Institution
The management of myelofibrosis with anemia is becoming increasingly nuanced given the several JAK inhibitors available to us and the potential for add-on therapies! An excellent resource to consider regarding decision-making is PMID 39808793. Regarding this specific question on-hand, I am assuming ...
Sign In or Register to read more